AstraZeneca
Director, AI Research
$186K–$279K
US - Boston - MA · Director · Full-time · Posted Oct 27, 2026
- Experience
- Eight years of original research and technical impact.
- Education
- PhD in Computer Science, Machine Learning, Biostatistics, Biomedical Informatics, Computational Biology, or a closely related quantitative field, or an MSc with an equivalent record of research and industry impact.
About the job
Leads AI research for clinical development, creating and evaluating methods and systems that improve clinical-trial decisions across Oncology and BioPharmaceuticals.
What you'll do
- Set and deliver a research roadmap focused on high-impact clinical-development challenges.
- Develop and evaluate AI and statistical-learning methods and agentic systems for clinical trials, with reproducible engineering and responsible governance.
- Provide scientific leadership, mentor researchers, and share results through publications, tools, patents, and partnerships.
What they ask for
- PhD in a relevant quantitative field, or MSc with an equivalent record of research and industry impact.
- Eight years of original research and technical impact.
- Led substantial research programs end to end and made decisions shaping a broader portfolio, platform, or organizational direction.
- Strong Python and scientific-computing skills, and experience with a modern ML framework such as PyTorch, JAX, or TensorFlow.
Nice to have
- Experience with biomedical data, such as clinical text, EHR or trial data, imaging, or genomics.
- Hands-on experience with large language models or agentic systems, including fine-tuning, retrieval-augmented generation, tool use, or evaluation.
Pay
$186,014 to $279,021 USD (base salary)
Tools
Python, PyTorch, JAX, TensorFlow
AI focus
Research and develop foundation models, multimodal learning, agentic AI, post-training, and evaluation methods for clinical development; apply these to trial design and analysis, and establish responsible evaluation and governance.
Model-written summary · the original posting is authoritative